Hyperglycemia and Cardiovascular Outcomes With Type 2 Diabetes

NCT00191282 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1116

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Acute Myocardial Infarction

Interventions

DRUG: Insulin lispro
DRUG: Human insulin isophane suspension (NPH)
DRUG: Insulin glargine
DRUG: Human insulin isophane suspension
DRUG: Human insulin 30/70

Sponsor

Eli Lilly and Company